U bevindt zich op: Home › Onderwerpen › R › Rijksvaccinatieprogramma › English summary Rijksvaccinatieprogramma
The Netherlands has an extensive National Immunisation Programme to protect children against infectious diseases. The programme includes vaccination against 12 potentially fatal infectious diseases.
While participation is not compulsory, over 95% of parents consent to having their children vaccinated. It is essential that children complete the vaccination cycle as scheduled. The Immunisation Programme is free of charge.
The Netherlands has an extensive National Immunisation
Programme to protect children against infectious diseases. These
difficult to treat and potentially fatal infectious diseases are:
• Diphtheria (D)
• Pertussis (whooping cough) (K)
• Tetanus (T)
• Poliomyelitis (Polio)
• Disease due to Haemophilus influenza type B (Hib)
• Pneumococcal disease (Pneu)
• Hepatitis B (HepB)
• Mumps (B)
• Measles (M)
• Rubella (German measles) (R)
• Meningococcal disease due to serogroup C (MenC)
• Cervical cancer (HPV).
To ensure that children receive maximum protection against these
diseases, vaccinations are given in four steps:
Step 1: At the age of 2, 3, 4, 11 and 14 months
Step 2: At age four years
Step 3: At age nine years
Step 4: At age twelve years
As from august 2011 all babies receive
also vaccination against hepatitis B. Infants whose mothers
are hepatitis B carriers also receive hepatitis B vaccination
within 48 hours of birth.
It is essential that children complete the vaccination cycle as scheduled. If, for reasons of illness or periods out of the Netherlands, your child has not been vaccinated as scheduled, you need to seek medical advice to ensure that your child receives adequate protection.
The Immunisation Programme is free of charge. While participation is not compulsory, over 95% of parents consent to having their children vaccinated. The high vaccination rate means that these serious diseases have now become a rarity. We need to keep it that way by ensuring that children are vaccinated.